Imagine you are building a discounted cash flow model for a manufacturing firm. You reach the section for calculating net working capital and spot a long-term loan installment due in four months. As an analyst, you must decide whether to treat this as a current or non-current liability. Your classification here directly impacts your free cash flow projection and your liquidity assessment, which in turn alters your conviction regarding the firm’s short-term solvency.
Under Schedule III of the Companies Act 2013, the distinction between current and non-current assets or liabilities hinges primarily on the ‘operating cycle’—the time elapsed between acquiring assets for processing and their realization in cash. If a company cannot clearly identify its operating cycle, the statute dictates a default period of twelve months. This regulatory threshold is not merely a box-ticking exercise; it is the fundamental benchmark for assessing whether a firm can meet its near-term financial obligations from its own internal resource generation.
Consider an infrastructure developer with a 15-month project lifecycle. In this instance, the operating cycle extends beyond the standard one-year period, meaning items like long-term receivables linked to that specific project may be classified as current assets. Conversely, a retail chain with rapid inventory turnover must classify even minor liabilities as current if they are due within their twelve-month cycle. Failing to distinguish between these operational realities can lead you to miscalculate the quick ratio, effectively blinding you to a potential liquidity crunch hidden in plain sight.
Effective valuation relies on this granular classification because it separates permanent capital from temporary funding. When you analyze a company, look past the labels and examine the underlying cash flow dynamics. If you blindly accept the Balance Sheet presentation without verifying if a liability should be reclassified due to impending maturity dates, your sensitivity analysis will likely be flawed. By standardizing these items correctly, you transition from a reader of accounting reports to a strategic evaluator of corporate health.
Nuance
Check Your Understanding
A pharmaceutical company has an operating cycle of 14 months for its R&D intensive projects. A loan installment amounting to ₹50 lakhs is payable in 13 months. How should this be classified on the Balance Sheet under the Companies Act 2013?
Which of the following would be correctly classified as a ‘Current Asset’ under the standard interpretation of the Companies Act 2013, assuming a standard 12-month operating cycle?
This is a companion read for Section 8.3 — Balance Sheet from PASS Research Analyst Certification Examination by Akhilesh Gururani, available on Amazon Kindle.
Copyright © 2026 Akhilesh Gururani. All rights reserved.